NASK SRL
The score of NASK shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -86 % Total assets -91 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NASK's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
NASK's financial analysis
- Solvency100.0%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NASK
NASK's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0743.913.982
- VAT number
- BE0743913982
- Peppol
- Registered · 0208:0743913982 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Feb 2020
- Registered office
- 1700 Dilbeek
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
NASK (SRL) has been based in Dilbeek since 2020, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 1,178 € and equity of 2,027 €; its revenue is not published. Its solvency stands at 100.0%, above the median of its sector (60.4%).
Companies similar to NASK
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- JCK Research and experimental development on natural sciences and engineering Montigny-le-Tilleul · balance sheet 1,364 €
- RK21 Research and experimental development on natural sciences and engineering Hamois · balance sheet 3,336 €
- LAB.001 Research and experimental development on natural sciences and engineering Brussels · balance sheet 5,303 €
- Phagomed Research and experimental development on natural sciences and engineering Izegem · balance sheet 8,901 €
- Indagen Research and experimental development on natural sciences and engineering Antwerp · balance sheet 10,059 €
Frequently asked questions about NASK
What is the revenue of NASK?
NASK files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NASK?
In Belgium, the VAT number is the company number prefixed with BE: BE0743913982 for NASK, if the company is VAT-registered. Its company number (CBE) is 0743.913.982.
Where is the registered office of NASK?
According to the CBE register, the registered office of NASK is in 1700 Dilbeek.
What is the equity of NASK?
At the close of the 2025 financial year, the equity of NASK amounts to 2,027 €, a solvency of 100.0% of total assets.
Who manages NASK?
The register lists 1 active mandates at NASK. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NASK
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →